AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Birlotib 150 Tablet

Prescription Icon
Prescription Required

Marketer

BDR Pharmaceuticals Internationals Pvt

Salt Composition

Erlotinib (150mg)

Overview Birlotib 150 Tablet

Birlotib 150mg tablets treat non-small cell lung and pancreatic cancers. Administer on an empty stomach, or one hour before or two hours after eating. Continue treatment as directed by your physician; duration depends on individual response. Strictly adhere to your doctor's instructions; incorrect usage or overdose may cause severe adverse effects. Benefits may take weeks or months to appear; do not discontinue without consulting your doctor. Common side effects include nausea, vomiting, tiredness, skin rash, and weight loss. Severe diarrhea requires increased fluid intake or medical attention. Photosensitivity necessitates protective clothing and sunscreen. Report mouth sores, vision changes, or breathing problems immediately. Regular liver function monitoring may be recommended. Inform your healthcare provider of all medications you are taking, as interactions are possible. This medication is contraindicated during pregnancy and breastfeeding; effective contraception is crucial for both partners. Smoking cessation is advised as it can impair medication efficacy. Maintain a two-hour interval between Birlotib 150mg and antacids or other medications.

Uses of Birlotib 150 Tablet

Cancers of the pancreas and non-small-cell lung

Major Benefits of Birlotib 150 Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the entire tablet without chewing, crushing, or fracturing it. The Birlotib 150 Tablet should be taken on an empty stomach.

Common Side effects of Birlotib 150 Tablet:

  • Abdominal pain
  • Bone pain
  • Breathlessness
  • Constipation
  • Cough
  • Diarrhea
  • Fatigue
  • Fever
  • Infection
  • Muscle pain
  • Nausea
  • Rash
  • Stomatitis (Inflammation of the mouth)
  • Vomiting
  • Weight loss

How to use Birlotib 150 Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Birlotib 150 Tablet whole; avoid chewing, crushing, or breaking it. Administer on an empty stomach.

How Birlotib 150 Tablet works:

Lonafenib 150mg tablets are a cancer treatment. Lung cancer cells possess epidermal growth factor receptors (EGFRs) which regulate their proliferation. The drug functions by attaching to these EGFR receptors, thereby blocking the cancer-promoting signals they transmit. This mechanism effectively curtails the expansion of malignant cells.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

Alcohol consumption alongside Birlotib 150 Tablet may pose unknown risks; seek medical advice before combining them.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Birlotib 150 Tablet during pregnancy poses a confirmed risk to the fetus. Therefore, its use is contraindicated. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Birlotib 150 Tablet while breastfeeding is likely inadvisable. Available human data indicates a potential for the medication to transfer to breast milk, posing a risk to the infant.

DrivingDrivingCONSULT YOUR DOCTOR

The effect of Birlotib 150 Tablet on driving ability is unknown. Refrain from driving if experiencing symptoms impairing concentration or reaction time.

KidneyKidneySAFE IF PRESCRIBED

Birlotib 150 Tablets can be used by patients with kidney disease without altering the dosage. However, its use is contraindicated in individuals with severe kidney impairment.

LiverLiverCAUTION

Patients with hepatic impairment should use Birlotib 150mg tablets cautiously; dosage modification may be necessary. Physician consultation is advised.

What if you forget to take Birlotib 150 Tablet :

Omit any missed Birlotib 150 Tablet dose and resume your usual medication regimen. Avoid taking a double dose.

Facts to Know About Birlotib 150 Tablet

LabelValue
Type of Compound Benzopyrimidine compound
Addictive None.
Medication Category Cancer-fighting drugs

FAQs on Birlotib 150 Tablet

Take one Birlotib 150 Tablet orally daily, as directed by your physician. For optimal absorption, administer the tablet on an empty stomach, at least one hour before or two hours after eating. Consistent daily timing is recommended to aid adherence to the prescribed regimen.
Birlotib 150 Tablet is not a standard chemotherapy agent. Classified as a kinase inhibitor, it functions by inhibiting the activity of a faulty protein responsible for signaling cancer cell proliferation. This mechanism contributes to a reduction or cessation of cancer cell growth.
Continue daily ingestion of Birlotib 150 Tablet under your physician's direction. Treatment length is individualized.
Smoking significantly impairs the efficacy of Birlotib 150 Tablet. It can substantially reduce the medication's effectiveness. Therefore, cessation of smoking prior to commencing Birlotib 150 Tablet is recommended. Continued smoking, or any alteration in smoking habits, will require your physician to modify the Birlotib 150 Tablet dosage.
Skin irritation is a frequent reaction to Birlotib 150 Tablet; however, discontinuation of Birlotib 150 Tablet is not recommended due to this. Seek medical advice for managing the rash. Additionally, minimize sun exposure, apply sunscreen, and utilize protective garments.
Refrain from conception during treatment with Birlotib 150 Tablet. Women of childbearing potential should utilize reliable contraception throughout treatment. Post-treatment, postpone pregnancy for at least one month following the final dose.
Conjunctivitis and dry eyes are frequently reported side effects of Birlotib 150 Tablet. Seek immediate medical attention if you experience sudden or intensifying eye redness and pain, excessive tearing, visual blurring, and/or light sensitivity, as prompt treatment may be necessary.
Report any sudden shortness of breath accompanied by cough or fever, persistent or intense diarrhea, appetite loss, nausea, or vomiting to your physician. Additionally, seek medical attention if you develop or experience worsening eye redness and pain, excessive tearing, blurry vision, and/or light sensitivity. Disclose to your doctor if you are concurrently using a statin (cholesterol-lowering medication) and develop inexplicable muscle aches, soreness, weakness, or spasms.
Birlotib 150 Tablet
732
MRP 892
17% off